column
    Efficacy and safety of two dose regimens of rituximab for idiopathic membranous nephropathy
    Tu Zhi-hui, Yang Ding-ping
    2024, 24(2): 89-95. DOI: 10.3969/j.issn.1671-2390.2024.02.001
    Abstract PDF
    Anticoagulation application of nafamostat mesylate in patients on continuous renal replacement therapy at a high risk of hemorrhage
    Ding Jia-rong, Zhang Huan, Chen Wei, Zhao Jun-hua, Liang Xin-rui, Guo Zhi-yong
    2024, 24(2): 96-102. DOI: 10.3969/j.issn.1671-2390.2024.02.002
    Abstract PDF
    Application and efficacy analysis of rituximab in the treatment of childhood primary nephrotic syndrome in Ningxia
    Yang Wu, Wang Xiao-e, Gu Jia-le, Ma Li-juan, Su Bai-ge, Xiao Hui-jie, Yao Yong, Zhang Hong-wen
    2024, 24(2): 103-107. DOI: 10.3969/j.issn.1671-2390.2024.02.003
    Abstract PDF
    Efficacy and safety of rituximab dosing for steroid-resistant idiopathic focal segmental glomerulosclerosis: a report of 12 cases
    Peng Ying-chao, Zhang Zhi-qiang, Wang Mei-qiu, Fang Xiang, Gao Chun-lin, Sun Tao, Xia Zheng-kun
    2024, 24(2): 108-115. DOI: 10.3969/j.issn.1671-2390.2024.02.004
    Abstract PDF
    Predictive significance of predialysis plasma osmolality for frequent intradialytic hypotension in elders on maintenance hemodialysis
    Jiang Xiao-hong, Weng Li-na
    2024, 24(2): 116-120. DOI: 10.3969/j.issn.1671-2390.2024.02.005
    Abstract PDF
    Diagnostic values of serum levels of stromal interaction molecule 1 and retinol binding protein 4 in patients with hypertensive nephropathy
    Zhou Lin, Li Jing, Li Yi, Zhao Ming
    2024, 24(2): 121-127. DOI: 10.3969/j.issn.1671-2390.2024.02.006
    Abstract PDF
    lncRNA-C920021L13Rik depletion lessened high glucose-induced mesangial cell injury through regulating miR-2861
    Sun Lin-lin, Zhu Ding-yu, Chen Fu-hua, Ding Miao, Xie Xin-miao
    2024, 24(2): 128-135. DOI: 10.3969/j.issn.1671-2390.2024.02.007
    Abstract PDF
    Role of indoxyl sulfate in the progression of chronic kidney disease and associated cardiovascular diseases
    He Yan-yan, Wang Li-hua
    2024, 24(2): 136-142. DOI: 10.3969/j.issn.1671-2390.2024.02.008
    Abstract PDF
    Research advances of mRNA methylation in kidney diseases
    Zhang Shi-wen, Luan Jun-jun, Zhou Hua
    2024, 24(2): 143-150. DOI: 10.3969/j.issn.1671-2390.2024.02.009
    Abstract PDF
    Research advances on hypoxia inducible factor and diabetic nephropathy
    Ma Ye-ping, Li Zhong-xin.
    2024, 24(2): 151-154. DOI: 10.3969/j.issn.1671-2390.2024.02.010
    Abstract PDF
    Research advances on the role of ubiquitin proteasome in podocyte injury of diabetic kidney disease
    Wang Jin, Dai Wen-ling, Liu Ji-hua
    2024, 24(2): 155-159. DOI: 10.3969/j.issn.1671-2390.2024.02.011
    Abstract PDF
    Research advances of caspases in acute kidney injury
    Duan Hao-nan, Wang Xiao-yan
    2024, 24(2): 160-167. DOI: 10.3969/j.issn.1671-2390.2024.02.012
    Abstract PDF
    Neural epidermal growth factor-like 1 protein related segmental membrane nephropathy: one case report
    Lei Qing, Zhu Han, Li Yue-qiang, Chang Xiao-yan, Pei Guang-chang, Liu Liu
    2024, 24(2): 168-170. DOI: 10.3969/j.issn.1671-2390.2024.02.013
    Abstract PDF
    Dent disease manifested as Fanconi syndrome and early onset renal dysfunction: a pedigree report with a literature review
    Wang Li-xia, Ma Li-juan, Zhang Hong-wen
    2024, 24(2): 171-174. DOI: 10.3969/j.issn.1671-2390.2024.02.014
    Abstract PDF
    Differentiation of lifetime versus lifelong
    Liu Jin
    2024, 24(2): 175-176. DOI: 10.3969/j.issn.1671-2390.2024.02.015
    Abstract PDF